The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $88.55

Today's change+2.00 +2.31%
Updated July 25 4:15 PM EDT. Delayed by at least 15 minutes.
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $88.55

Today's change+2.00 +2.31%
Updated July 25 4:15 PM EDT. Delayed by at least 15 minutes.

Gilead Sciences Inc Hits New 50-day High

Gilead Sciences Inc closed up sharply Monday, rallying (U.S.)$2.00 or 2.31% to (U.S.)$88.55 and setting a new 50-day high. Over the last five days, shares have gained 1.86%, but are down 12.49% for the last year to date. Shares have underperformed the S&P 500 by 25.79% during the last year.

Key company metrics

  • Open(U.S.) $86.57
  • Previous close(U.S.) $86.55
  • High(U.S.) $88.85
  • Low(U.S.) $86.28
  • Bid / Ask(U.S.) $85.00 / (U.S.) $85.05
  • YTD % change-12.49%
  • Volume15,718,506
  • Average volume (10-day)9,170,263
  • Average volume (1-month)9,182,161
  • Average volume (3-month)9,800,592
  • 52-week range(U.S.) $77.92 to (U.S.) $120.37
  • Beta1.11
  • Trailing P/E7.58×
  • P/E 1 year forward7.20×
  • Forward PEG9.18×
  • Indicated annual dividend(U.S.) $1.88
  • Dividend yield2.12%
  • Trailing EPS(U.S.) $11.69
Updated July 25 4:15 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.70%Sector:HealthcareIndustry:Biotechnology

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue7,7948,5068,2958,244
Total other revenue--------
Total revenue7,7948,5068,2958,244
Gross profit6,6017,4447,2317,246
Total cost of revenue1,1931,0621,064998
Total operating expense3,1432,8852,7102,628
Selling / general / administrative6851,066903812
Research & development1,265757743818
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income4,6515,6215,5855,616
Interest income (expense), net non-operating-230-230-165-140
Gain (loss) on sale of assets--------
Other--------
Income before tax4,5025,4375,4725,511
Income after tax3,5674,6854,5924,497
Income tax, total9357528801,014
Net income3,5664,6834,6004,492
Total adjustments to net income--------
Net income before extra. items3,5664,6834,6004,492
Minority interest-1-28-5
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,5664,6834,6004,492
Inc. avail. to common incl. extra. items3,5664,6834,6004,492
Diluted net income3,5664,6834,6004,492
Dilution adjustment00----
Diluted weighted average shares1,4121,4701,5031,540
Diluted EPS excluding extraordinary itemsvalue per share2.533.193.062.92
Dividends per sharevalue per share0.430.430.430.43
Diluted normalized EPSvalue per share2.643.193.062.92